OUR COMPLETE SYSTEM FOR BETTER PROTECTION AND GLUCOSE CONTROL1

When combining Continuous Glucose monitoring with the MiniMed™ 640G System and the new Guardian™  2 Link transmitter, patients will benefit from:

  • Improvement in sensor accuracy in all glycaemic ranges2
  • The intelligence of SmartGuard™, offering hypoglycaemia protection by automatically stopping insulin delivery when sensor glucose is predicted to approach a pre-set low limit (*)
  • 83% of users felt more confident in managing highs and lows when wearing their CGM system3

Insertion is easy

  • One button insertion process
  • Hidden needle during insertion
  • 90 degree insertion angle

FIND OUT MORE ABOUT THE NEW GENERATION ENLITE INSERTION IN THIS VIDEO.

 

 

CGM REDUCES HBA1C AND IMPROVES GLYCAEMIC CONTROL

Several randomised controlled trials1,4,5 showed that CGM can lead to:

  • Up to 1% HbA1c reduction without increasing the rate of severe hypoglycaemia
  • Tighter glycaemic control
  • Greater number of patients reaching the HbA1c target recommended by the American Diabetes Association  (ADA)

All of these benefits can help you to achieve better control of your diabetes.

New Generation Enlite™ sensor is indicated for adults and children and only intended for use with Medtronic products: MiniMed™ 640G System, MiniMed™ Veo™ System, iPro™2, Guardian™ Connect.